Unusual Public-Private Partnership In The Pharmaceutical Industry

May 29, 2013

A collaboration between GlaxoSmithKline and the U.S. government is the first of its kind, and it may address what many consider a fundamental problem in how  the direction of drug research is determined.

 

Read full article at:

Daily Updates

Sign up for our free daily newsletter for the latest news and business legal developments.

Scroll to Top